Skip to content
CancerIndex

Publication

Activation of FGF receptors by mutations in the transmembrane domain.

Authors not recorded

Oncogene1997PMID 9136983stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (2)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 2

Curated evidence

Evidence citing this paper (1)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
9136983
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–1 of 1 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
FGFR3 G380R1
(functional)—UNRESOLVEDFunctionalDSupports Gain Of Function3accepted
EID10368

G380R mutation was created in the transmembrane region of murine FGFR3 to study its effect. An in vitro kinase assay using 293 human cells found the mutant FGFR3 to be expressed at levels similar or s… (full text at CIViC)

PMID 9136983 · Li et al., 1997 · Open in CIViC

civic